Supply tensions in sertraline: measures and recommendations to ensure the continuity of treatments

News

Date: 1st Apr, 2025 Source: N/A Country: N/A Original Source

Brief

On 01/04/2025, the French National Agency for the Safety of Medicines and Health Products (ANSM) issued an update regarding Supply tensions in sertraline: measures and recommendations to ensure the continuity of treatments. The agency reported supply tensions due to production problems at laboratories, which are expected to normalize by May 2025. To ensure treatment continuity, ANSM developed recommendations for doctors, in collaboration with professional organizations such as the CNPP, CNUP, and AFPBN.

This content is restricted.

Highlights content goes here...

This content is restricted.

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Supply tensions in sertraline: measures and recommendations to ensure the continuity of treatments

Brief

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Supply tensions in sertraline: measures and recommendations to ensure the continuity of treatments

Brief

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.